Discovery of Potent and Selective Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitors as Methuosis Inducers
Journal of Medicinal Chemistry · 11.01.2024 · 67 (1) · 165-179
DOI: 10.1021/acs.jmedchem.3c01039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.12.2023. Verfasst von Yong Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Center of Nursing Research and Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University/West China School of Nu…. Hauptthemen laut MEDLINE: Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Sichuan University, West China Hospital, Sichuan University, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Cytoplasmic vacuolation-associated cell death, known as methuosis, offers a promising nonapoptotic approach for cancer treatment. In this study, we outline the synthesis and evaluation of potent methuosis-inducing compounds. These compounds selectively induce cell death, characterized by extensive cytoplasmic vacuolation in HeLa and MDA-MB-231 cells. Notably, compound L22 exhibited a remarkable interaction with PIKfyve kinase, boasting a Kd value of 0.47 nM, surpassing the positive controls D-13 and MOMIPP in potency. Furthermore, it is important to highlight that cell death induced by compound L22 is unequivocally attributed to methuosis as it differs from apoptosis, necrosis, or autophagy. Importantly, when administered orally, L22 effectively inhibited tumor growth in a HeLa xenograft model without any apparent signs of toxicity. These results underscore the potential of L22 as a valuable tool for in-depth investigations into the mechanisms of methuosis and as a promising lead compound to guide structural optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Innovation Center of Nursing Research and Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu 610041, China.
- Laboratory of Natural and Targeted Small Molecule Drugs, State Key Laboratory of Biotherapy and Cancer Center and Collaborative Innovation Center of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041,…
- Chengdu Zenitar Biomedical Technology Co., Ltd., Chengdu 610041, China.
ORCID-Profile: Tao Yang, Zhuang Yang, Haoyu Ye, Lijuan Chen
Förderung
- Sichuan University
- West China Hospital, Sichuan University
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Liu, S., Wei, Y., Wei, H., Yuan, X., Xiong, B., Tang, M., Yang, T., Yang, Z., Ye, H., Yang, J., & Chen, L. (2024). Discovery of Potent and Selective Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitors as Methuosis Inducers. Journal of Medicinal Chemistry, 67(1), 165-179. https://doi.org/10.1021/acs.jmedchem.3c01039
Vancouver
Chen Y, Liu S, Wei Y, Wei H, Yuan X, Xiong B, et al. Discovery of Potent and Selective Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitors as Methuosis Inducers. Journal of Medicinal Chemistry. 2024;67(1):165-179. doi:10.1021/acs.jmedchem.3c01039
BibTeX
@article{Chen2024,
author = {Chen, Yong and Liu, Shuai and Wei, Yuhan and Wei, Haoche and Yuan, Xue and Xiong, Baojian and Tang, Minghai and Yang, Tao and Yang, Zhuang and Ye, Haoyu and Yang, Jianhong and Chen, Lijuan},
title = {Discovery of Potent and Selective Phosphatidylinositol 3-Phosphate 5-Kinase (PIKfyve) Inhibitors as Methuosis Inducers},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {1},
pages = {165--179},
doi = {10.1021/acs.jmedchem.3c01039}
}
EUVIMED